Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk

Dow Jones03-19

2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He points out that ASX-listed pathology provider Sonic has put considerable effort into the launch of the so-called MetaPanel test, holding deep cross-organization training events and a nationwide series of launch events. He tells clients in a note that MetaPanel is differentiated by its ability to detect more than three times as many pathogens than existing competitor tests. Bell Potter keeps a buy rating and A$0.35 target price on the stock, which is at A$0.19 ahead of the open. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

March 18, 2024 18:57 ET (22:57 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2420232229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-19 06:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2420232229","market":"nz","top_or_hot":-1,"title":"Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He points out that ASX-listed pathology provider Sonic has put considerable effort into the launch of the so-called MetaPanel test, holding deep cross-organization training events and a nationwide series of launch events. He tells clients in a note that MetaPanel is differentiated by its ability to detect more than three times as many pathogens than existing competitor tests. Bell Potter keeps a buy rating and A$0.35 target price on the stock, which is at A$0.19 ahead of the open. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 18, 2024 18:57 ET (22:57 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 06:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHL.AU","symbol_name":"SONIC HEALTHCARE LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2420232229","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2420232229","pubTimestamp":1710802620,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He points out that ASX-listed pathology provider Sonic has put considerable effort into the launch of the so-called MetaPanel test, holding deep cross-organization training events and a nationwide series of launch events. He tells clients in a note that MetaPanel is differentiated by its ability to detect more than three times as many pathogens than existing competitor tests. Bell Potter keeps a buy rating and A$0.35 target price on the stock, which is at A$0.19 ahead of the open. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SHL.AU":"SONIC HEALTHCARE LTD","MAP.AU":"MICROBA LIFE SCIENCES LTD"},"translate_title":"Microba的国内收入将从Sonic合作伙伴关系中获得提升——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHL.AU":1,"MAP.AU":0.9},"content_text":"2257 GMT - Microba Life Sciences' domestic revenues will be boosted by the roll-out of its gastrointestinal infectious disease test via Sonic Healthcare, Bell Potter analyst Thomas Wakim says. He points out that ASX-listed pathology provider Sonic has put considerable effort into the launch of the so-called MetaPanel test, holding deep cross-organization training events and a nationwide series of launch events. He tells clients in a note that MetaPanel is differentiated by its ability to detect more than three times as many pathogens than existing competitor tests. Bell Potter keeps a buy rating and A$0.35 target price on the stock, which is at A$0.19 ahead of the open. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2024 18:57 ET (22:57 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420232229"}